Proliferation Inhibition, DNA Damage, and Cell-Cycle Arrest of Human Astrocytoma Cells after Acrylamide Exposure

被引:33
作者
Chen, Jong-Hang [1 ]
Tsou, Tsui-Chun [2 ]
Chiu, Ing-Ming [3 ,4 ]
Chou, Chin-Cheng [1 ,5 ]
机构
[1] Natl Taiwan Univ, Dept Vet Med, Taipei 106, Taiwan
[2] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan 350, Miaoli County, Taiwan
[3] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 350, Miaoli County, Taiwan
[4] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[5] Natl Taiwan Univ, Coll Bioresources & Agr, Ctr Zoonoses Res, Taipei 106, Taiwan
关键词
FIBRILLARY ACIDIC PROTEIN; HUMAN NEUROBLASTOMA-CELLS; CENTRAL-NERVOUS-SYSTEM; GROWTH; ACTIVATION; PROMOTER; AGENT; KI-67; PHOSPHORYLATION; ONCOGENICITY;
D O I
10.1021/tx1000893
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Acrylamide (ACR) has been recognized as a neurological and reproductive toxin in humans and laboratory animals. This study aimed to determine the effects of ACR-induced DNA damage on cell cycle regulation in human astrocytoma cell lines. Treatment of U-I 240 MG cells with 2 mM ACR for h resulted hi a significant inhibition of cell proliferation as evaluated by Ki-67 protein expression and MTT assay. The analysis of DNA damage with the comet assay showed that treatment of the cells with 0.5, 1, and 2 mM ACR for 48 h caused significant increases in DNA damage by 3.5-, 4-, and 14-fold, respectively. Meanwhile, analysis of cell-cycle arrest with flow cytometry revealed that the ACR treatments resulted in significant increases in the G(0)/G(1)-arrested cells in a time- and dose-dependent manner. Expression of DNA damage-associated/checkpoint-related signaling molecules, including phosphorylated-p53 (pp53), p53, p21, p27, Cdk2, and cyclin D-1, in three human astrocytoma cell lines (U-1240 MG, U-251 MG, and U-87 MG) was also analyzed by immunoblotting. Treatment of the three cell lines with 2 mM ACR for 48 h caused marked increases in pp53 and Cdk2, as well as decreases in cyclin D-1 and p27. Moreover, increases in p53 and p21 were detected in both U-I240 and U-87 MG cells, whereas no marked change in p53 and a decrease in p21 were observed in U-251 MG cells. To address the involvement of ataxia telangiectasia mutated/ATM-Rad3-related (ATM/ATR) kinase in the signaling of ACR-induced G(0)/G(1) arrest, caffeine was used to block the ATM/ATR pathway in U-1240 MG cells. Caffeine significantly attenuated the ACR-induced G(0)/G(1) arrest as well as the expression of DNA damage-associated/checkpointrelated signaling molecules in a dose-dependent manner. This in vitro study clearly demonstrates the critical role of ATM/ATR in the signaling of ACR-induced cell-cycle arrest in astrocytoma cells.
引用
收藏
页码:1449 / 1458
页数:10
相关论文
共 57 条
[1]  
[Anonymous], 2002, CONS HLTH IMPL ACR F
[2]   Regulation of CDK/cyclin complexes during the cell cycle [J].
Arellano, M ;
Moreno, S .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (04) :559-573
[3]   Effects of acrylamide on primary neonatal rat astrocyte functions. [J].
Aschner, M ;
Wu, Q ;
Friedman, MA .
NEUROPROTECTIVE AGENTS, 2005, 1053 :444-454
[4]   The acute effects of acrylamide on astrocyte functions [J].
Aschner, M ;
Cao, CC ;
Wu, Q ;
Friedman, MA .
NEUROPROTECTIVE AGENTS, 2003, 993 :296-304
[5]  
BARRES BA, 1991, J NEUROSCI, V11, P3685
[6]   Caffeine inhibits the checkpoint kinase ATM [J].
Blasina, A ;
Price, BD ;
Turenne, GA ;
McGowan, CH .
CURRENT BIOLOGY, 1999, 9 (19) :1135-1138
[7]   Acrylamide-induced astrogliotic and apoptotic responses in human astrocytoma cells [J].
Chen, Jong-Hang ;
Wu, Kuen-Yuh ;
Chiu, Ing-Ming ;
Tsou, Tsui-Chun ;
Chou, Chin-Cheng .
TOXICOLOGY IN VITRO, 2009, 23 (05) :855-861
[8]   ALTERATIONS IN THE GLIAL FIBRILLARY ACIDIC PROTEIN-CONTENT OF PRIMARY ASTROCYTE CULTURES FOR EVALUATION OF GLIAL-CELL TOXICITY [J].
COOKSON, MR ;
PENTREATH, VW .
TOXICOLOGY IN VITRO, 1994, 8 (03) :351-&
[9]  
Friedberg E.C., 1995, DNA REPAIR MUTAGENES, P135
[10]   A LIFETIME ONCOGENICITY STUDY IN RATS WITH ACRYLAMIDE [J].
FRIEDMAN, MA ;
DULAK, LH ;
STEDHAM, MA .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1995, 27 (01) :95-105